Cargando…
Activated Kras(G12D) is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
BACKGROUND: Pancreatic cancer (PC) harbours an activated point mutation (Kras(G12D)) in the Kras proto-oncogene that has been demonstrated to promote the development of PC. METHODS: This study was designed to investigate the effect of the oncogenic Kras(G12D) allele on aggressiveness and metastatic...
Autores principales: | Rachagani, S, Senapati, S, Chakraborty, S, Ponnusamy, M P, Kumar, S, Smith, L M, Jain, M, Batra, S K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065271/ https://www.ncbi.nlm.nih.gov/pubmed/21364589 http://dx.doi.org/10.1038/bjc.2011.31 |
Ejemplares similares
-
Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway
por: Pandey, P, et al.
Publicado: (2013) -
CXCR2 signaling regulates KRAS((G12D))-induced autocrine growth of pancreatic cancer
por: Purohit, Abhilasha, et al.
Publicado: (2016) -
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2009) -
The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients
por: Blechschmidt, K, et al.
Publicado: (2008) -
E-cadherin involved in inactivation of WNT/β-catenin signalling in urothelial carcinoma and normal urothelial cells
por: Thievessen, I, et al.
Publicado: (2003)